NeuroOne Medical TechnologiesNMTC
13F holders, Q2 2025 (June 30)1holders
0new positions
0sold out
$0.68avg. 13F price*
At the end of Q2 2025, 1 institutions reported holding NeuroOne Medical Technologies (NMTC) in their 13F filings, unchanged from Q1 2025. 0 opened new positions and 0 sold out. The largest holder was AWM Investment Company, Inc. ($622K).
- Company
- NeuroOne Medical Technologies
- CUSIP
- 64130M100
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 250,000 shares sold, net −250,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| AWM Investment Company, Inc. | 0.07% | Reduce -21.4% | 916,667 | $622K |
"% of holder's portfolio" is NMTC's weight in each manager's 13F, not the share of NeuroOne Medical Technologies the manager owns.